China Alectinib Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Alectinib market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Alectinib market. Detailed analysis of key players, along with key growth strategies adopted by Alectinib industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Roche

    • Everest Pharmaceuticals

    By Type:

    • 150mg*140 Capsules

    • 150mg*28 Capsules

    • 20mg*1 Capsule

    • 40mg*1 Capsule

    • 150mg*26 Capsules

    By End-User:

    • Unresectable NSCLC

    • Advanced NSCLC

    • Recurrent NSCLC

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Alectinib Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Alectinib Market Size and Growth Rate of 150mg*140 Capsules from 2016 to 2027

    • 1.3.2 China Alectinib Market Size and Growth Rate of 150mg*28 Capsules from 2016 to 2027

    • 1.3.3 China Alectinib Market Size and Growth Rate of 20mg*1 Capsule from 2016 to 2027

    • 1.3.4 China Alectinib Market Size and Growth Rate of 40mg*1 Capsule from 2016 to 2027

    • 1.3.5 China Alectinib Market Size and Growth Rate of 150mg*26 Capsules from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Alectinib Market Size and Growth Rate of Unresectable NSCLC from 2016 to 2027

    • 1.4.2 China Alectinib Market Size and Growth Rate of Advanced NSCLC from 2016 to 2027

    • 1.4.3 China Alectinib Market Size and Growth Rate of Recurrent NSCLC from 2016 to 2027

    • 1.4.4 China Alectinib Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Alectinib Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Alectinib by Major Types

    • 3.4.1 Market Size and Growth Rate of 150mg*140 Capsules

    • 3.4.2 Market Size and Growth Rate of 150mg*28 Capsules

    • 3.4.3 Market Size and Growth Rate of 20mg*1 Capsule

    • 3.4.4 Market Size and Growth Rate of 40mg*1 Capsule

    • 3.4.5 Market Size and Growth Rate of 150mg*26 Capsules

    4 Segmentation of Alectinib Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Alectinib by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Alectinib in Unresectable NSCLC

    • 4.4.2 Market Size and Growth Rate of Alectinib in Advanced NSCLC

    • 4.4.3 Market Size and Growth Rate of Alectinib in Recurrent NSCLC

    • 4.4.4 Market Size and Growth Rate of Alectinib in Other

    5 Market Analysis by Regions

    • 5.1 China Alectinib Production Analysis by Regions

    • 5.2 China Alectinib Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Alectinib Landscape Analysis

    • 6.1 North China Alectinib Landscape Analysis by Major Types

    • 6.2 North China Alectinib Landscape Analysis by Major End-Users

    7 Central China Alectinib Landscape Analysis

    • 7.1 Central China Alectinib Landscape Analysis by Major Types

    • 7.2 Central China Alectinib Landscape Analysis by Major End-Users

    8 South China Alectinib Landscape Analysis

    • 8.1 South China Alectinib Landscape Analysis by Major Types

    • 8.2 South China Alectinib Landscape Analysis by Major End-Users

    9 East China Alectinib Landscape Analysis

    • 9.1 East China Alectinib Landscape Analysis by Major Types

    • 9.2 East China Alectinib Landscape Analysis by Major End-Users

    10 Northeast China Alectinib Landscape Analysis

    • 10.1 Northeast China Alectinib Landscape Analysis by Major Types

    • 10.2 Northeast China Alectinib Landscape Analysis by Major End-Users

    11 Southwest China Alectinib Landscape Analysis

    • 11.1 Southwest China Alectinib Landscape Analysis by Major Types

    • 11.2 Southwest China Alectinib Landscape Analysis by Major End-Users

    12 Northwest China Alectinib Landscape Analysis

    • 12.1 Northwest China Alectinib Landscape Analysis by Major Types

    • 12.2 Northwest China Alectinib Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Roche

      • 13.1.1 Roche Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Everest Pharmaceuticals

      • 13.2.1 Everest Pharmaceuticals Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Alectinib Market Size and Growth Rate of 150mg*140 Capsules from 2016 to 2027

    • Figure China Alectinib Market Size and Growth Rate of 150mg*28 Capsules from 2016 to 2027

    • Figure China Alectinib Market Size and Growth Rate of 20mg*1 Capsule from 2016 to 2027

    • Figure China Alectinib Market Size and Growth Rate of 40mg*1 Capsule from 2016 to 2027

    • Figure China Alectinib Market Size and Growth Rate of 150mg*26 Capsules from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Alectinib Market Size and Growth Rate of Unresectable NSCLC from 2016 to 2027

    • Figure China Alectinib Market Size and Growth Rate of Advanced NSCLC from 2016 to 2027

    • Figure China Alectinib Market Size and Growth Rate of Recurrent NSCLC from 2016 to 2027

    • Figure China Alectinib Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Alectinib Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Alectinib Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Alectinib

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Alectinib by Different Types from 2016 to 2027

    • Table Consumption Share of Alectinib by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of 150mg*140 Capsules

    • Figure Market Size and Growth Rate of 150mg*28 Capsules

    • Figure Market Size and Growth Rate of 20mg*1 Capsule

    • Figure Market Size and Growth Rate of 40mg*1 Capsule

    • Figure Market Size and Growth Rate of 150mg*26 Capsules

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Alectinib by Different End-Users from 2016 to 2027

    • Table Consumption Share of Alectinib by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Unresectable NSCLC

    • Figure Market Size and Growth Rate of Advanced NSCLC

    • Figure Market Size and Growth Rate of Recurrent NSCLC

    • Figure Market Size and Growth Rate of Other

    • Table China Alectinib Production by Regions

    • Table China Alectinib Production Share by Regions

    • Figure China Alectinib Production Share by Regions in 2016

    • Figure China Alectinib Production Share by Regions in 2021

    • Figure China Alectinib Production Share by Regions in 2027

    • Table China Alectinib Consumption by Regions

    • Table China Alectinib Consumption Share by Regions

    • Figure China Alectinib Consumption Share by Regions in 2016

    • Figure China Alectinib Consumption Share by Regions in 2021

    • Figure China Alectinib Consumption Share by Regions in 2027

    • Table North China Alectinib Consumption by Types from 2016 to 2027

    • Table North China Alectinib Consumption Share by Types from 2016 to 2027

    • Figure North China Alectinib Consumption Share by Types in 2016

    • Figure North China Alectinib Consumption Share by Types in 2021

    • Figure North China Alectinib Consumption Share by Types in 2027

    • Table North China Alectinib Consumption by End-Users from 2016 to 2027

    • Table North China Alectinib Consumption Share by End-Users from 2016 to 2027

    • Figure North China Alectinib Consumption Share by End-Users in 2016

    • Figure North China Alectinib Consumption Share by End-Users in 2021

    • Figure North China Alectinib Consumption Share by End-Users in 2027

    • Table Central China Alectinib Consumption by Types from 2016 to 2027

    • Table Central China Alectinib Consumption Share by Types from 2016 to 2027

    • Figure Central China Alectinib Consumption Share by Types in 2016

    • Figure Central China Alectinib Consumption Share by Types in 2021

    • Figure Central China Alectinib Consumption Share by Types in 2027

    • Table Central China Alectinib Consumption by End-Users from 2016 to 2027

    • Table Central China Alectinib Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Alectinib Consumption Share by End-Users in 2016

    • Figure Central China Alectinib Consumption Share by End-Users in 2021

    • Figure Central China Alectinib Consumption Share by End-Users in 2027

    • Table South China Alectinib Consumption by Types from 2016 to 2027

    • Table South China Alectinib Consumption Share by Types from 2016 to 2027

    • Figure South China Alectinib Consumption Share by Types in 2016

    • Figure South China Alectinib Consumption Share by Types in 2021

    • Figure South China Alectinib Consumption Share by Types in 2027

    • Table South China Alectinib Consumption by End-Users from 2016 to 2027

    • Table South China Alectinib Consumption Share by End-Users from 2016 to 2027

    • Figure South China Alectinib Consumption Share by End-Users in 2016

    • Figure South China Alectinib Consumption Share by End-Users in 2021

    • Figure South China Alectinib Consumption Share by End-Users in 2027

    • Table East China Alectinib Consumption by Types from 2016 to 2027

    • Table East China Alectinib Consumption Share by Types from 2016 to 2027

    • Figure East China Alectinib Consumption Share by Types in 2016

    • Figure East China Alectinib Consumption Share by Types in 2021

    • Figure East China Alectinib Consumption Share by Types in 2027

    • Table East China Alectinib Consumption by End-Users from 2016 to 2027

    • Table East China Alectinib Consumption Share by End-Users from 2016 to 2027

    • Figure East China Alectinib Consumption Share by End-Users in 2016

    • Figure East China Alectinib Consumption Share by End-Users in 2021

    • Figure East China Alectinib Consumption Share by End-Users in 2027

    • Table Northeast China Alectinib Consumption by Types from 2016 to 2027

    • Table Northeast China Alectinib Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Alectinib Consumption Share by Types in 2016

    • Figure Northeast China Alectinib Consumption Share by Types in 2021

    • Figure Northeast China Alectinib Consumption Share by Types in 2027

    • Table Northeast China Alectinib Consumption by End-Users from 2016 to 2027

    • Table Northeast China Alectinib Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Alectinib Consumption Share by End-Users in 2016

    • Figure Northeast China Alectinib Consumption Share by End-Users in 2021

    • Figure Northeast China Alectinib Consumption Share by End-Users in 2027

    • Table Southwest China Alectinib Consumption by Types from 2016 to 2027

    • Table Southwest China Alectinib Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Alectinib Consumption Share by Types in 2016

    • Figure Southwest China Alectinib Consumption Share by Types in 2021

    • Figure Southwest China Alectinib Consumption Share by Types in 2027

    • Table Southwest China Alectinib Consumption by End-Users from 2016 to 2027

    • Table Southwest China Alectinib Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Alectinib Consumption Share by End-Users in 2016

    • Figure Southwest China Alectinib Consumption Share by End-Users in 2021

    • Figure Southwest China Alectinib Consumption Share by End-Users in 2027

    • Table Northwest China Alectinib Consumption by Types from 2016 to 2027

    • Table Northwest China Alectinib Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Alectinib Consumption Share by Types in 2016

    • Figure Northwest China Alectinib Consumption Share by Types in 2021

    • Figure Northwest China Alectinib Consumption Share by Types in 2027

    • Table Northwest China Alectinib Consumption by End-Users from 2016 to 2027

    • Table Northwest China Alectinib Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Alectinib Consumption Share by End-Users in 2016

    • Figure Northwest China Alectinib Consumption Share by End-Users in 2021

    • Figure Northwest China Alectinib Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Everest Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Everest Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Everest Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Everest Pharmaceuticals

    • Table Product and Service Introduction of Everest Pharmaceuticals


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.